SOCS1 and lymphoma: In comparison to the distribution of SOCS1 mutations in other lymphomas [18, 20, 26], point mutations in cHL showed a higher prevalence in the SH3 domain, whereas deletions predominantly affected the JAK Kinase Domain (Figure 1b, Supplementary Table S2).